XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Compare 401(k) options by evaluating index funds against target date funds to see which aligns with your retirement plan and risk tolerance.
25,660 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Matrixport’s fear index shows mounting pessimism as Bitcoin whipsaws in a volatile market. While downside risk remain...
Starting with $1,000 can jumpstart a lasting investing habit. This guide shows practical ways to pick the best stocks...
As the trillion private credit market swells, a new risk signal emerges: more loans are under tighter, unrealized ter...
In 2025, Mackenzie Scott gave away $7.2 billion, setting a new standard for billionaire philanthropy and pushing her ...
U.S.-Israel strikes on Iran trigger sharp market moves as Trump calls regime change, raising the stakes for investors...
Geopolitical risk spikes as Iran tensions flare, sending markets skittish and reshaping household budgets in the mont...
Bitcoin prices retreat toward $60,000 while the Fear & Greed Index hits Extreme Fear. Here’s how traders assess risk,...
A high-profile moment in a living room reveals a bigger truth: politics at home can ripple into your wallet. This art...
As travel rebounds, premium demand is reshaping cruise stock dashboards. This deep dive explains why norwegian cruise...
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
A large insider sale often sparks questions about a company’s future. This article breaks down what the move means, h...